Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunovant (IMVT) Depreciation & Amortization (CF) (2019 - 2026)

Immunovant filings provide 7 years of Depreciation & Amortization (CF) readings, the most recent being $101000.0 for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 2.02% to $101000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $422000.0 through Dec 2025, up 27.11% year-over-year, with the annual reading at $377000.0 for FY2025, 63.2% up from the prior year.
  • Depreciation & Amortization (CF) hit $101000.0 in Q4 2025 for Immunovant, down from $105000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $109000.0 in Q1 2025 and bottomed at $22000.0 in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $63100.0, with a median of $55000.0 recorded in 2023.
  • The largest annual shift saw Depreciation & Amortization (CF) soared 266.67% in 2021 before it grew 2.02% in 2025.
  • Immunovant's Depreciation & Amortization (CF) stood at $33000.0 in 2021, then skyrocketed by 48.48% to $49000.0 in 2022, then grew by 18.37% to $58000.0 in 2023, then soared by 70.69% to $99000.0 in 2024, then grew by 2.02% to $101000.0 in 2025.
  • Per Business Quant, the three most recent readings for IMVT's Depreciation & Amortization (CF) are $101000.0 (Q4 2025), $105000.0 (Q3 2025), and $107000.0 (Q2 2025).